abemaciclib,anastrozole,letrozole
eli lilly,novartis
['breast', 'vance', 'monarch 3', 'bcsm']
at #esmo22 we re presenting data from the second interim analysis of monarch 3, a first line trial of a cdk4 &amp; 6 inhibitor plus a nonsteroidal aromatase inhibitor in postmenopausal women w/ hr+, her2- advanced #breastcancer. #bcsm view the presentation: 
Dedicated to communicating the latest science & innovation from Loxo@Lilly. Tweets intended for US oncology HCPs. See our community guidelines: https://t.co/1q8vAe63mK